west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "Graves病" 2 results
  • Correlation between Chinese Population Cytotoxic T Lymphocytes Associated Antigen-4 Gene Exon-1 & Promoter Polymorphisms and Graves’ Disease: A Meta-Analysis

    Objective To systematically evaluate correlation between exon-1 (locus 49, A/G) and promoter (locus -318, C/T) polymorphisms of Chinese population cytotoxic T lymphocytes associated antigen-4 (CTLA-4) gene and Graves’ Disease (GD). Methods Relevant studies were electronically searched in CNKI, VIP, CBM, PubMed, EMbase and The Cochrane Library from 1980.1 to 2011.12. According to the inclusion and exclusion criteria, we selected and screened all case-control studies on the correlation between CTLA-4 exon -1 (locus 49, A/G) and promoter (locus -318, C/T) polymorphisms of Chinese population and GD. Then we extracted the data and assessed the methodological quality of the included studies. Meta-analysis was performed using RevMan 5.0 and STATA 12.0 software. Results (1) Ten studies on exon-1 were included. Results of meta-analyses showed that Chinese population with genotype G/G had a higher GD risk than those with genotype A/A (OR=3.38, 95%CI 2.07 to 5.51) and A/G (OR=1.72, 95%CI 1.31 to 2.25). Also, the allele G showed significant association with increased GD risk compared to the allele A (OR=1.87, 95%CI 1.44 to 2.41). (2) Five studies on promoter-318 were included. Results of meta-analyses showed that Chinese population with genotype T/T presented no increased relative risk compared to those with genotype C/C (OR=0.75, 95%CI 0.26 to 2.12) or C/T (OR=0.92, 95%CI 0.31 to 2.73). Meanwhile, the allele T showed no increased relative risk compared to the allele C (OR=0.83, 95%CI 0.61 to 1.12). Conclusion The allele G at the locus 49 of exon -1 of Chinese population is significantly associated with increased GD risks, yet the correlation between promoter –318 C/T polymorphism and GD hasn’t been demonstrated. Due to the limited quality and quantity of the included studies, more high-quality studies are needed to test the above conclusion.

    Release date:2016-09-07 10:58 Export PDF Favorites Scan
  • 免疫球蛋白G4相关性甲状腺疾病

    免疫球蛋白 G4 相关性疾病(immunoglobulin G4-related disease,IgG4-RD)是本世纪初新认识的可累及包括内分泌系统特别是甲状腺的全身多器官系统疾病,以免疫介导的纤维化炎症为主要病理特征。免疫球蛋白 G4 相关甲状腺疾病(immunoglobulin G4-related thyroid disease,IgG4-RTD)是很少被考虑到的一类甲状腺疾病,既可单独累及甲状腺也可同时累及其他器官。目前认为 IgG4-RTD 包括 4 种亚型:Riedel 甲状腺炎、桥本甲状腺炎的纤维样变型、免疫球蛋白 G4(immunoglobulin G4,IgG4)相关性桥本甲状腺炎和 Graves 病合并 IgG4 升高。其诊断较为复杂,需结合临床表现、组织学特征和血清学证据综合判断。大多数情况下,可根据经典的组织病理学表现诊断 IgG4-RTD,因此强烈推荐在治疗前进行活检。IgG4-RTD 的治疗包括药物治疗和手术治疗,虽然可能需要进一步证据,类固醇仍是一线治疗药物。他莫昔芬和利妥昔单抗是类固醇抵抗患者的二线治疗药物。对于有压迫症状患者应选择行甲状腺切除。到目前为止,该病的病理生理机制尚未完全明确,早期及时诊断、早期治疗可明显改善预后。

    Release date:2018-05-24 02:12 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content